AKT1 and neoplasm: PD-1 inhibitor-mediated upregulation of TIM-3 could deplete tumor-infiltrating lymphocytes (TILs) and generate tumor escape by phosphatidylinositol 3 kinase (PI3K)/Akt complexes downstream of the TCR signaling.